FDA Recall – FreeStyle Libre 3 and Libre 3 Plus Sensors
- Details
- Published: Sunday, 07 December 2025 18:16
- Written by Sara Jones
The FDA has issued a Class I recall for specific lot numbers of FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitoring sensors due to the potential for inaccurately low glucose readings.
This recall does NOT affect:
Patients may start asking about this recall. Please see the FDA notification below, which includes a link to the full list of affected lot numbers.
Recommended patient counseling points:
- Always confirm surprisingly low (or symptomatic) sensor readings with a fingerstick blood glucose test.
- Patients should immediately check any sensors they have at home against the affected lot list.
- If they have affected sensors, they can request free replacement sensors directly from Abbott using the online process (link and instructions below).
- Until unaffected sensors are received, patients without spare unaffected sensors should monitor glucose exclusively with fingerstick testing.
Early Alert: Glucose Monitor Sensor Issue from Abbott Diabetes Care | FDA
Sara Jones, Pharm D.
Consulting Pharmacist
Northwest Human Services
503-480-1626